(CNS) Cohen Steers - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US19247A1007

CNS: Mutual Funds, Hedge Funds, Real Estate, Commodities, Fixed Income

Cohen & Steers, Inc. (NYSE: CNS) is a leading global investment manager with a distinct focus on real assets and alternative income strategies. Founded in 1986 and headquartered in New York, the firm has built a reputation for its expertise in navigating complex markets, particularly in sectors that require specialized knowledge.

The firm primarily serves institutional investors, including pension funds, endowments, and foundations, offering tailored solutions through its subsidiaries. Its investment strategies span equities, fixed income, commodities, and multi-asset portfolios, with a strong emphasis on sectors like real estate, infrastructure, and natural resources. Cohen & Steers is particularly known for its proficiency in preferred securities, a niche area that requires a deep understanding of market dynamics and structural nuances.

Through its subsidiaries, the company manages a diverse range of investment vehicles, including mutual funds, hedge funds, and separate accounts. This flexibility allows it to cater to the varied needs of its clients, from traditional equity and fixed-income strategies to more specialized approaches like commodity investing. Its global reach is evident in its ability to identify and capitalize on opportunities in both developed and emerging markets.

Cohen & Steers has established itself as a trusted partner for investors seeking exposure to real assets and alternative income streams. Its ability to balance risk and return in these often-volatile sectors has made it a go-to manager for institutions looking to diversify their portfolios. The firms long-term track record and specialized focus position it as a key player in the asset management industry.

From a financial perspective, Cohen & Steers operates with a market capitalization of approximately $4.39 billion, reflecting its significant presence in the market. The firms price-to-earnings ratio stands at 29.24, with a forward P/E of 30.12, indicating investor confidence in its future prospects. Its price-to-book ratio of 9.16 and price-to-sales ratio of 8.84 highlight its valuation relative to its assets and revenue.

For investors and fund managers, Cohen & Steers offers a compelling combination of expertise, diversification, and access to alternative income streams. Its focus on real assets and specialized sectors makes it a valuable addition to portfolios seeking stability and growth in uncertain markets.

Ticker Symbol: CNS Exchange: NYSE Type: Common Stock Country Origin: United States GICS Sub Industry: Asset Management & Custody Banks Market Cap or AUM: $4.39B USD P/E: 29.24 P/E Forward: 30.12 P/B: 9.16 P

Additional Sources for CNS Stock

CNS Stock Overview

Market Cap in USD 4,311m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception 2004-08-13

CNS Stock Ratings

Growth 5y 41.4%
Fundamental 34.2%
Dividend 51.9%
Rel. Strength Industry -3.89
Analysts 3.67/5
Fair Price Momentum 72.72 USD
Fair Price DCF 19.03 USD

CNS Dividends

Dividend Yield 12m 2.78%
Yield on Cost 5y 3.67%
Annual Growth 5y 1.69%
Payout Consistency 86.0%

CNS Growth Ratios

Growth Correlation 3m -90.4%
Growth Correlation 12m 78%
Growth Correlation 5y 48.4%
CAGR 5y 6.05%
CAGR/Max DD 5y 0.11
Sharpe Ratio 12m 0.73
Alpha 6.18
Beta 0.87
Volatility 30.16%
Current Volume 186.3k
Average Volume 20d 178.7k
What is the price of CNS stocks?
As of February 22, 2025, the stock is trading at USD 86.33 with a total of 186,333 shares traded.
Over the past week, the price has changed by +1.25%, over one month by -3.22%, over three months by -15.35% and over the past year by +24.98%.
Is Cohen Steers a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cohen Steers is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNS as of February 2025 is 72.72. This means that CNS is currently overvalued and has a potential downside of -15.77%.
Is CNS a buy, sell or hold?
Cohen Steers has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CNS.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CNS stock price target?
According to ValueRays Forecast Model, CNS Cohen Steers will be worth about 87.3 in February 2026. The stock is currently trading at 86.33. This means that the stock has a potential upside of +1.09%.
Issuer Forecast Upside
Wallstreet Target Price 93.3 8.1%
Analysts Target Price 97.7 13.1%
ValueRay Target Price 87.3 1.1%